Condition

Gallbladder Cancer

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 17 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials17
Recruiting1
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

17 shown
Integrated Cancer Repository for Cancer ResearchNCT02012699 · 2013-11-01
RECRUITING
Proteomic Analysis of Patients Undergoing Bariatric SurgeryNCT06787807 · 2025-06-10
NOT_YET_RECRUITING
To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsNCT05253053 · 2022-04-13
COMPLETED
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsNCT04742959 · 2021-03-14
COMPLETED
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsNCT04383210 · 2020-09-29
TERMINATED
Behavioral Weight Loss Program for Cancer Survivors in MarylandNCT04534309 · 2020-09-22
COMPLETED
International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)NCT03210298 · 2016-01-01
UNKNOWN
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive CancerNCT02293954 · 2015-11-11
ACTIVE_NOT_RECRUITING
Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal CancerNCT00836992 · 2009-01-01
COMPLETED
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial TherapyNCT00896467 · 2007-09-01
TERMINATED
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.NCT00423254 · 2007-02-01
COMPLETED
Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal CancerNCT00387348 · 2006-03-01
TERMINATED
Vaccine Therapy in Treating Patients With Advanced or Metastatic CancerNCT00027534 · 2002-01-01
COMPLETED
Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have CancerNCT00588263 · 2000-07-01
WITHDRAWN
Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasNCT00019513 · 1998-08-01
COMPLETED
Interleukin-12 in Treating Patients With Cancer in the AbdomenNCT00003046 · 1997-08-01
COMPLETED
Biological Therapy in Treating Patients With Metastatic CancerNCT00004604 · 1997-02-01
COMPLETED

Common interventions

Trial status mix

COMPLETED9
TERMINATED3
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
RECRUITING1
UNKNOWN1
WITHDRAWN1

Phase mix

PHASE17
NA3
PHASE23
PHASE31
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.